Literature DB >> 8482584

Polymorphism and phylogeny of dinucleotide repeats in human T-cell receptor Vb6 genes.

P Charmley1, P Concannon.   

Abstract

The Vb6 subfamily is the largest reported subfamily of human T-cell receptor (Tcr) genes, with as many as 14 possible members based on variation in reported DNA sequences. A study of the genomic organization of four distinct Vb6 genes indicated that they contained within their introns the uninterrupted dinucleotide repeat (GT)n, with n > 8. DNA amplification primers and conditions were determined which amplified the intron of these four different Vb6 gene segments. All four Vb6 genes tested showed length polymorphism when examined in a group of unrelated individuals. Careful sizing and DNA sequencing showed that the alleles of each gene differed in size by multiples of two base pairs (bp), due to different repeat numbers of the dinucleotide (GT)n. These four microsatellite polymorphisms had from three to ten alleles, and individual heterozygosities of 26% to 83%. The large number of alleles and the high heterozygosity make these polymerase chain reaction (PCR)-based polymorphisms very attractive genetic markers for segregation studies which postulate the presence of autoimmune susceptibility genes within the Tcrb region. Vb6 hybridization to genomic DNA confirmed the relatively large size of the Vb6 subfamily in several hominoid species. Nucleotide sequencing of an intron of the Vb6 genes from other primates revealed the presence of dinucleotide repeats similar to those found in human Vb6 genes. Thus, the (GT)n microsatellite was not only present in the Vb6 intron before Vb6 gene duplication, but was present before speciation of the hominoids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482584     DOI: 10.1007/bf00190896

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  19 in total

1.  Construction of a GT polymorphism map of human 9q.

Authors:  D J Kwiatkowski; E P Henske; K Weimer; L Ozelius; J F Gusella; J Haines
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

2.  Genetic and physical maps of human chromosome 4 based on dinucleotide repeats.

Authors:  K A Mills; K H Buetow; Y Xu; J L Weber; M R Altherr; J J Wasmuth; J C Murray
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

3.  Continuous linkage map of human chromosome 14 short tandem repeat polymorphisms.

Authors:  Z Wang; J L Weber
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

4.  A genetic linkage map of human chromosome 20 composed entirely of microsatellite markers.

Authors:  J Hazan; C Dubay; M P Pankowiak; N Becuwe; J Weissenbach
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

5.  Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.

Authors:  J Dausset; H Cann; D Cohen; M Lathrop; J M Lalouel; R White
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

6.  The antigen receptor of an autoreactive T-cell clone from human rheumatic synovia.

Authors:  A E Hinkkanen; V Steimle; M Schlesier; H H Peter; J T Epplen
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Allelic sequence variations in the hypervariable region of a T-cell receptor beta chain: correlation with restriction fragment length polymorphism in human families and populations.

Authors:  M A Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 8.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

9.  T-cell receptor genes and insulin-dependent diabetes mellitus (IDDM): no evidence for linkage from affected sib pairs.

Authors:  P Concannon; J A Wright; L G Wright; D R Sylvester; R S Spielman
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

10.  The genomic structure of human V beta 6 T cell antigen receptor genes.

Authors:  Y Li; P Szabo; D N Posnett
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  7 in total

1.  Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls.

Authors:  M K Hockertz; D W Paty; S S Beall
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

2.  The extent of the human germline T-cell receptor V beta gene segment repertoire.

Authors:  S Wei; P Charmley; M A Robinson; P Concannon
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  The nonfunctional allele TCRBV6S1B is strongly associated with Helicobacter pylori infection.

Authors:  E Kunstmann; C Hardt; E Elitok; M Harder; S Suerbaum; U Peitz; W Schmiegel; J T Epplen
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.

Authors:  C A MacRae; N Ghaisas; S Kass; S Donnelly; C T Basson; H C Watkins; R Anan; L H Thierfelder; K McGarry; E Rowland
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  PCR-based genotyping and haplotype analysis of human TCRBV gene segment polymorphisms.

Authors:  P Charmley; P Concannon
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients.

Authors:  M Gomolka; H Menninger; J E Saal; E M Lemmel; E D Albert; O Niwa; J T Epplen; C Epplen
Journal:  J Mol Med (Berl)       Date:  1995-01       Impact factor: 4.599

7.  Genetic analysis of low V beta 3 expression in humans.

Authors:  J P Donahue; N S Ricalton; C E Behrendt; C Rittershaus; S Calaman; P Marrack; J W Kappler; B L Kotzin
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.